Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
(NASDAQ: PRME) Delayed: 3.14 +0.14 (4.67%)
Previous Close $3.00    52 Week High $21.72 
Open $3.11    52 Week Low $18.36 
Day High $3.39    P/E N/A 
Day Low $3.10    EPS $0.00 
Volume 3,253,758